Drug Profile
Monoclonal antibody MX-DTPA BrE-3
Alternative Names: MX-DTPA BrE-3Latest Information Update: 22 Aug 2002
Price :
$50
*
At a glance
- Originator Nonindustrial sources
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Breast cancer
Most Recent Events
- 26 Aug 1998 New profile
- 26 Aug 1998 Phase-I clinical trials for Breast cancer in USA (IV-infusion)